New endoscopic procedure aims to help people with obesity lose weight
NCT ID NCT05713071
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new procedure called BEAM (Bariatric Endoscopic Antral Myotomy) to help people with obesity lose weight. The procedure uses a tube down the throat to make small cuts in the stomach muscle, aiming to change how the stomach empties. Twenty adults with a BMI between 30 and 50 will be followed for a year to see if it is safe and helps with weight loss.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bariatric Endoscopic Antral Myotomy (BEAM) procedure
- What this could lead to
- If successful, BEAM could offer a less invasive weight-loss option for people with obesity, potentially reducing the need for more major surgery.
- What could go wrong
- This is a very small pilot study with only 20 people, so results may not apply broadly. The procedure is new and long-term safety and effectiveness are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Feb 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Subjects must be 18-70 years of age 2. Are currently in the CWMW lifestyle modification program 3. Have a diagnostic endoscopy approved for bariatric evaluation 4. Eligible for endoscopic and surgical weight loss procedures 5. Body mass index (BMI) 30-50 kg/m2 6. Individuals must be in excellent mental health 7. Able to understand and sign informed consent 8. Available to return for all routine follow-up study visits Exclusion Criteria: 1. Untreated H. pylori infection 2. Active smoking 3. Ongoing or a history of treatment with opioids in the last 12 months prior to enrollment 4. Previous pyloromyotomy or pyloroplasty 5. Gastrointestinal obstruction 6. Severe coagulopathy 7. Esophageal or gastric varices and/or portal hypertensive gastropathy 8. Pregnancy or puerperium 9. Any inflammatory disease of the gastrointestinal tract (including but not limited to severe (LA Grade C or D) esophagitis, active gastric ulceration, active duodenal ulceration, or specific inflammation such as Crohn's disease) 10. Malignant or premalignant gastric diseases (such as high grade dysplasia, gastric cancer, or GIST) 11. Severe cardiopulmonary disease or a history of coronary artery disease (including myocardial infarction within the past 6 months, poorly controlled hypertension, required use of NSAIDs) 12. Lactation 13. History of gastrointestinal surgery 14. Any serious health condition unrelated to their weight that would increase the risk of endoscopy 15. Chronic abdominal pain 16. Active psychological issues preventing participation in a lifestyle modification program 17. A known history of endocrine disorders affecting weight (uncontrolled hypothyroidism) 18. An inability to provide informed consent 19. Use of any medication that may interfere with weight loss 20. Use of any medication that may interfere with gastric emptying 21. Any other condition which the investigator may deem as an impediment to compliance or hinder completion of the proposed study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delayed gastric emptying following procedure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?